Similar to TGFα-PE40, DAB389EGF has been investigated for the treatment of bladder cancers, demonstrating potent killing of bladder cancer cells in vitro and elimination of tumor burden in five of six mice in vivo [91]. This evidence concerns the gene TGFA and urinary bladder carcinoma.